Goldman Says Cephid (CPHD) is 'Oversold'; Likes New Products, L-T Growth Outlook

Article Stock Quotes (1) Comments (0)

Cephid (Nasdaq: CPHD) might get a boost this afternoon following comments from Goldman Sachs.

The firm said shares are "oversold" and investors were likely discouraged by fiscal 2013 operating margin forecast.

However, following Cephid's Analyst Day today, Goldman sees a "healthy" long-term growth story on solid new product announcements and long-term revenue guidance.

Goldman sees Cephid remaining the leader in the rapid MDx market.

Shares are down 8 percent on the session following preliminary third-quarter numbers issued Wednesday night.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Bulls and Bears Do Battle in Aeropostale (ARO); Turnaround Intact?
• InterOil (IOC) Gets Blue Chip 'Stamp of Approval', But Talks Ongoing
• UPDATE: Crash in American Electric Power (AEP) & NextEra Energy (NEE) Adds to Jitters

Create E-mail Alert Related Categories

Analyst Comments, Trader Talk

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?